<DOC>
	<DOCNO>NCT00264693</DOCNO>
	<brief_summary>Low molecular weight heparin ( LMWH ) show least efficient safe unfractioned heparin ( UFH ) prophylaxis treatment venous thromboembolic event therapy acute cardiovascular disease . LMWH widely use safe replacement oral anticoagulation vitamin K antagonist ( VKA ) . Due pharmacokinetic characteristic , LMWH tend accumulate patient impaired renal function . Official guideline recommend therefore use LMWH control Anti-Xa level use UFH instead LMWH provide full therapeutic anticoagulation therapy patient severe renal insufficiency . Although dosage recommendation propose enoxaparin patient renal impairment base several study , data apply LMWH directly due different pharmacokinetic property drug . The present study aim clarify pharmacokinetics dalteparin patient renal insufficiency , especially address question accumulation multiple dos include patient severe renal insufficiency derive safe suitable concept use dalteparin patient impaired renal function .</brief_summary>
	<brief_title>Pharmacokinetics Dalteparin Patients With Impaired Renal Function</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Patient start dalteparin prophylaxis OR therapy order treat physician ( evaluated clinical indication contraindication ) . Renal function normal OR impair without dialysis therapy accord open study group Age &gt; = 18 year Written inform consent Pregnancy / Lactation Dalteparin LMWH already use &gt; 1 day , unless use hemodialysis AntiXa level first application dalteparin &gt; 0.3 U / ml Participation another study Anuria OR glomerular filtration rate &lt; 10 ml/min without dialysis Patient intensive care unit ( ICU ) Cardiovascular unstable patient probable need quick stop anticoagulation ( e.g . emergency surgery ) Patient disease whose estimated life expectancy &lt; 28 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>